The conduct of clinical research is essential to improving the treatment options of cancer patients. Many treatment protocols are complex and prescribed using electronic health record systems where the treatment protocol orders have been built previously. The work of building these treatment protocols is a complex process involving many steps, substantial time, and can be the limiting step in opening clinical trials. Multi-arm and protocol amendments can be particularly time consuming to build. Unfortunately for multi-site clinical trials, this build process is duplicated at each site representing a lack of efficiency in the overall clinical research system. This project seeks to bring together a consortium of NCI-designated cancer centers who are leaders in both the conduct of clinical research and in clinical informatics, along with coordination with EHR companies, to establish standardized build conventions, develop means to make clinical trial protocol builds interoperable across sites, and ultimately to make the conduct of clinical research substantially more efficient. In this way we will be able to better leverage the power of clinical informatics systems to accelerate the conduct of clinical cancer research.

Public Health Relevance

Currently every center opening a trial is required to build its own trial calendar in its electronic health record (EHR) system. The focus of this supplement is to standardize the calendar build across multiple NCI designated cancer centers to increase the collective efficiency of opening trials. This will dramatically improve the timeline for trial opening, resulting in NCI Cancer Centers being able to deliver treatment options more quickly to patients. Additionally it will reduce cost for clinical research, enabling more research opportunities and at more locations outside of major academic centers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA046934-32S6
Application #
10225725
Study Section
Program Officer
He, Min
Project Start
1997-04-04
Project End
2022-01-31
Budget Start
2020-09-10
Budget End
2021-01-31
Support Year
32
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Kim, Seongsoon; Park, Donghyeon; Choi, Yonghwa et al. (2018) A Pilot Study of Biomedical Text Comprehension using an Attention-Based Deep Neural Reader: Design and Experimental Analysis. JMIR Med Inform 6:e2
Altieri, Lisa; Miller, Kimberly A; Huh, Jimi et al. (2018) Prevalence of sun protection behaviors in Hispanic youth residing in a high ultraviolet light environment. Pediatr Dermatol 35:e52-e54
Kwak, Jeff W; Laskowski, Jennifer; Li, Howard Y et al. (2018) Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Res 78:143-156
Hoefert, Jaimee E; Bjerke, Glen A; Wang, Dongmei et al. (2018) The microRNA-200 family coordinately regulates cell adhesion and proliferation in hair morphogenesis. J Cell Biol 217:2185-2204
Riemondy, Kent A; Gillen, Austin E; White, Emily A et al. (2018) Dynamic temperature-sensitive A-to-I RNA editing in the brain of a heterothermic mammal during hibernation. RNA 24:1481-1495
Sclafani, Robert A; Hesselberth, Jay R (2018) O Cdc7 kinase where art thou? Curr Genet 64:677-680
Shearn, Colin T; Orlicky, David J; Petersen, Dennis R (2018) Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease. Exp Mol Pathol 104:1-8
Kim, Jihye; Yoo, Minjae; Shin, Jimin et al. (2018) Systems Pharmacology-Based Approach of Connecting Disease Genes in Genome-Wide Association Studies with Traditional Chinese Medicine. Int J Genomics 2018:7697356
Coleman, Carrie B; Lang, Julie; Sweet, Lydia A et al. (2018) Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice. J Virol 92:
Petersen, Dennis R; Orlicky, David J; Roede, James R et al. (2018) Aberrant expression of redox regulatory proteins in patients with concomitant primary Sclerosing cholangitis/inflammatory bowel disease. Exp Mol Pathol 105:32-36

Showing the most recent 10 out of 1634 publications